Project Details
| Status | Active |
|---|---|
| Effective start/end date | 3/6/23 → 3/6/26 |
Funding
- Medpace Clinical Research LLC (Prot #RIV-HU6-2201 // Prot #RIV-HU6-2201)
- Rivus Pharmaceuticals, Inc. (Prot #RIV-HU6-2201 // Prot #RIV-HU6-2201)
Prot #RIV-HU6-2201: Exploratory Phase 2A, Double-Blind, Placebo-Controlled Dose Escalation Study to Determine the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of HU6 for the Treatment of Subjects with Obese Heart Failure with Preserved Eje
- Shah, Sanjiv J (PD/PI)
Project: Research project